Artyc · 1 week ago
Life Sciences Account Executive
Artyc is a company dedicated to modernizing cold chain logistics with a focus on environmental and social impact. They are seeking a Life Sciences Account Executive to independently manage the sales cycle, targeting hospitals, clinical research sites, and other life sciences organizations, with a strong emphasis on achieving revenue goals and maintaining pipeline discipline.
AnalyticsBiotechnologyLogisticsMedicalSupply Chain Management
Responsibilities
Develop and execute a sales plan: build and maintain target account list across our verticals with a focus on three main areas (1) Specialty Pharmacies, (2) Clinical Research (CROs, CDMOs) and (3) Universities and Biotechs
Own your funnel: prospect – cold calls, in person visits, conferences, run discovery, develop proposals, manage pilots, close deals
Maintain pipeline discipline: keep CRM data accurate, forecast reliably, and ensure pipeline coverage
Track progress: constantly measure activity, customer feedback, and report metrics
Qualification
Required
5-7+ years of experience
Life sciences sales background. Preferably has sold into pharma/hospitals/clinical sites
Quota carrying with history of exceeding quotas
Track record of managing 10+ SMB accounts at a time
Expert at CRM (Hubspot) and other prospecting tools (e.g. Apollo.io)
Proficient with AI GTM tools/agents
Preferred
Automate pipeline management
Independently write and manage contract process
Forecast and financial model (e.g. ROI analysis)
Ability to build new customer-focused features and tools
Clearly defined project management structure – metrics reporting is second nature
Medical cold chain requirement fluency
Benefits
Paid time off
Medical, Dental & Vision
401k
Company retreats, bi-weekly lunches, team events & more!
Company
Artyc
In today's world, temperature-sensitive goods are more crucial than ever.
Funding
Current Stage
Early StageTotal Funding
$10.68MKey Investors
Elemental ImpactSOSV
2024-12-11Convertible Note
2023-11-15Series Unknown
2023-06-30Series A· $10.68M
Recent News
2026-01-05
Google Patent
2025-05-04
Company data provided by crunchbase